FierceBiotech  2 hrs ago  Comment 
Tobira Therapeutics and Microlin Bio are pressing pause on their Wall Street hopes, postponing IPOs that would have totaled $88 million at their midpoint and falling victim to a back-and-forth market for biotech debuts.
SeekingAlpha  2 hrs ago  Comment 
By Life Sciences Report: Medical technology is intimately linked to regenerative medicine. You could say these industries have a thunder-and-lightning relationship-you can't have one without the other. Mark Landy, director of research for medical...
New York Times  4 hrs ago  Comment 
Biotech analysts say it is unlikely that drug companies will be put off by the Federal Reserve chairwoman's remarks at a Senate panel last month.
FierceBiotech  4 hrs ago  Comment 
More than 5 years after The Medicines Company bagged Targanta and its troubled antibiotic oritavancin for the bargain basement rate of $42 million plus potential bonus payments, the biotech has finally nailed down an elusive FDA approval of the...
Market Intelligence Center  4 hrs ago  Comment 
The patented option trade-picking algorithms behind's Artificial Intelligence Center have selected a covered call trade on First Trust NYSE Arca Biotech Index (FBT) that includes 1.82% downside protection. Sell one...
Market Intelligence Center  4 hrs ago  Comment 
Benzinga  8 hrs ago  Comment 
Below are the biotechnology stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Amgen (NASDAQ: AMGN) is $19.46 billion. Amgen's profit margin for the same period is 25.74%. The trailing-twelve-month...  10 hrs ago  Comment 
MARTINSRIED (dpa-AFX) - German biotechnology company Medigene Ag ( MDGEF.PK) Thursday reported narrower loss for the first half year, influenced by significant growth in revenues. The company's revenue from drug Veregen alone, rose 36 percent...
New York Times  Aug 7  Comment 
An experimental medicine that has been called a “secret serum” is being given to two Americans infected with Ebola.
FierceBiotech  Aug 6  Comment 
Cytori Therapeutics hit the brakes on a pair of clinical trials to find out why three patients in the study suffered from "cerebrovascular" events after they were treated with the biotech's experimental stem cell treatment. The San Diego-based...
SeekingAlpha  Aug 6  Comment 
By The Value Investor: Catalent (NYSE:CTLT) provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. The company is a key partner for the pharmaceutical and biotechnology industry...


Related Articles


Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors

Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share


  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009

M&A Biotechnology

Monoclonal Antibody Market 2009

Vaccine Market 2009

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs)

M&A Review: Pharmaceutical & Biotechnology Industry

Global Vaccine Market Review 2008 (World Top Ten Vaccines)

Ipilimumab (BMS) Review: A Cancer Breakthrough?

Denosumab (Prolia, Amgen) FDA Review & Approval

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki